AUS
NZ
UK
CA
USA
FRA
GER
ESP
ITA
NLD
PRT
SWE
GRC
IND
POL
BRA
ZAF
RUS
CHN
UAE
At the close of trading session on 10th January 2020, the Australian market ended in green and the benchmark index i.e. S&P/ASX200 showcased a rise of 54.8 points or 0.8% and reached at 6929. Let us now look at the performance of some sectors. S&P/ASX 200 Consumer Staples (Sector) settled at 12,706.1 with a rise of 199.3 points or 1.57%. On an intraday basis, S&P/ASX 200 Health Care (Sector) closed at 43,503.3, reflecting an increase of 2.07% or 899.8 points. On January 10, 2020, All Ordinaries stood at 7041.9 with a rise of 50.5 points.
Let’s look at the performance of some individual companies on 10th January 2020. Vocus Group Limited (ASX: VOC) closed the session at A$3.200 per share, up by 8.108%, and Orocobre Limited (ASX: ORE) closed at A$3.400, with a rise of 6.583%.
Let us also lens through the gainers and losers at NZX Main Board. Blackwell Global Holdings Limited (BGI) ended the session in green as there was a rise of 14.29% and closed at NZ$0.008. PaySauce Limited (PYS) closed at NZ$0.920 per share, reflecting an increase of 8.24% on an intraday basis. We will now have a look at some stocks which ended in red. SeaDragon Limited (SEA) witnessed a decline of 33.33% and reached at NZ$0.002 and New Talisman Gold Mines Limited (NTL) closed at NZ$0.007 per share reflecting a fall of 12.50%.
Recently, we have written some important information on Calima Energy Limited (ASX:CE1) and advise the readers to have a glance at the information provided. To view, please click here.
Vocus Group Limited Rose 8.108% on Australian Stock Exchange
Vocus Group Limited (ASX:VOC) has recently announced that Kevin Steven Russell has made a change to the holdings and has acquired 200,000 ordinary shares for a consideration of $594,399.51 on 9th January 2020. The company has announced that it has reached an agreement to settle the class action which was commenced against the company in April 2019 in the Federal Court of Australia. The settlement amount was $35 million (inclusive of interest and costs).
The company would contribute an amount of $3.5 million to the settlement, which would be reported as a significant item below underlying EBITDA. In another update, the company announced that Challenger Limited and its entities have made a change to their substantial holdings on 18th December 2019 and has increased its voting power to 9.30% as compared to the previous voting power of 8.18%.
AVITA Medical Ltd Closed the Session in Green
AVITA Medical Ltd (ASX:AVH) recently announced that The Bank of New York Mellon Corporation and each group entity has made a change to their holdings in the company and the current voting power has increased to 27.30% as compared to the previous voting power of 26.25%. In another update, the company announced that it has received approval for Investigational Device Exemption application from the U.S. Food and Drug Administration to conduct a feasibility study evaluating the safety and effectiveness of the RECELL® Autologous Cell Harvesting Device for repigmentation of depigmented lesions associated with stable vitiligo.
Disclaimer
This website is a service of Kalkine Media Pty. Ltd. A.C.N. 629 651 672. The website has been prepared for informational purposes only and is not intended to be used as a complete source of information on any particular company. Kalkine Media does not in any way endorse or recommend individuals, products or services that may be discussed on this site. Our publications are NOT a solicitation or recommendation to buy, sell or hold. We are neither licensed nor qualified to provide investment advice.
